Department of Biomolecular Engineering and CBSE, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Bioinformatics. 2012 Sep 15;28(18):i640-i646. doi: 10.1093/bioinformatics/bts402.
A current challenge in understanding cancer processes is to pinpoint which mutations influence the onset and progression of disease. Toward this goal, we describe a method called PARADIGM-SHIFT that can predict whether a mutational event is neutral, gain-or loss-of-function in a tumor sample. The method uses a belief-propagation algorithm to infer gene activity from gene expression and copy number data in the context of a set of pathway interactions.
The method was found to be both sensitive and specific on a set of positive and negative controls for multiple cancers for which pathway information was available. Application to the Cancer Genome Atlas glioblastoma, ovarian and lung squamous cancer datasets revealed several novel mutations with predicted high impact including several genes mutated at low frequency suggesting the approach will be complementary to current approaches that rely on the prevalence of events to reach statistical significance.
All source code is available at the github repository http:github.org/paradigmshift.
Supplementary data are available at Bioinformatics online.
理解癌症过程的一个当前挑战是精确定位哪些突变会影响疾病的发生和进展。为此,我们描述了一种称为 PARADIGM-SHIFT 的方法,该方法可以预测突变事件在肿瘤样本中是中性的、获得功能还是失去功能。该方法使用置信传播算法从基因表达和拷贝数数据中推断基因活性,这些数据是在一组通路相互作用的背景下进行的。
该方法在一组具有通路信息的多种癌症的阳性和阴性对照中表现出较高的敏感性和特异性。在癌症基因组图谱胶质母细胞瘤、卵巢和肺鳞癌数据集上的应用揭示了一些具有高预测影响的新突变,包括一些低频突变的基因,这表明该方法将与目前依赖事件的普遍性来达到统计学意义的方法互补。
所有源代码均可在 github 存储库 http://github.org/paradigmshift 上获得。
补充数据可在生物信息学在线获得。